OMIC / Singular Genomics Systems, Inc. (OMIC) CEO Drew Spaventa on Q1 2022 Results - Earnings Call Transcript

SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NG more_horizontal

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Philip Taylor - IR Drew more_horizontal

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Philip Taylor - IR Drew Spa more_horizontal

Similar Genomics Systems (OMIC) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compare more_horizontal

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Philip Taylor - Investor more_horizontal

Similar Genomics Systems (OMIC) delivered earnings and revenue surprises of 21.62% and 27.50%, respectively, for the quarter ended December 2022. Do t more_horizontal

Singular Genomics Systems is a unique opportunity to invest in a commercially-viable startup at the forefront of a rapidly expanding field. The compan more_horizontal

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Philip Taylor - Inves more_horizontal